These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7474150)

  • 1. Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein.
    Konvalinka J; Löchelt M; Zentgraf H; Flügel RM; Kräusslich HG
    J Virol; 1995 Nov; 69(11):7264-8. PubMed ID: 7474150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein.
    Löchelt M; Flügel RM
    J Virol; 1996 Feb; 70(2):1033-40. PubMed ID: 8551561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity.
    Konvalinka J; Litterst MA; Welker R; Kottler H; Rippmann F; Heuser AM; Kräusslich HG
    J Virol; 1995 Nov; 69(11):7180-6. PubMed ID: 7474139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboxy-terminal cleavage of the human foamy virus Gag precursor molecule is an essential step in the viral life cycle.
    Enssle J; Fischer N; Moebes A; Mauer B; Smola U; Rethwilm A
    J Virol; 1997 Oct; 71(10):7312-7. PubMed ID: 9311808
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of proteolytic processing of the Gag proteins of human spumavirus.
    Pfrepper KI; Löchelt M; Rackwitz HR; Schnölzer M; Heid H; Flügel RM
    J Virol; 1999 Sep; 73(9):7907-11. PubMed ID: 10438890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic processing of foamy virus Gag and Pol proteins.
    Flügel RM; Pfrepper KI
    Curr Top Microbiol Immunol; 2003; 277():63-88. PubMed ID: 12908768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prototype foamy virus protease activity is essential for intraparticle reverse transcription initiation but not absolutely required for uncoating upon host cell entry.
    Hütter S; Müllers E; Stanke N; Reh J; Lindemann D
    J Virol; 2013 Mar; 87(6):3163-76. PubMed ID: 23283957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of peptide substrates and viral enzyme that affect the cleavage site specificity of the human spumaretrovirus proteinase.
    Pfrepper KI; Reed J; Rackwitz HR; Schnölzer M; Flügel RM
    Virus Genes; 2001 Jan; 22(1):61-72. PubMed ID: 11210941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase.
    Stewart L; Vogt VM
    J Virol; 1991 Nov; 65(11):6218-31. PubMed ID: 1717719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The carboxy-terminal p3Gag domain of the human foamy virus Gag precursor is required for efficient virus infectivity.
    Zemba M; Wilk T; Rutten T; Wagner A; Flügel RM; Löchelt M
    Virology; 1998 Jul; 247(1):7-13. PubMed ID: 9683566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of the gag-pol precursor from human immunodeficiency virus type 1 proviral genomes results in efficient proteolytic processing in the absence of virion production.
    Park J; Morrow CD
    J Virol; 1991 Sep; 65(9):5111-7. PubMed ID: 1870215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of an infectious DNA clone of the full-length human spumaretrovirus genome and mutagenesis of the bel 1 gene.
    Löchelt M; Zentgraf H; Flügel RM
    Virology; 1991 Sep; 184(1):43-54. PubMed ID: 1651600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterisation and mutational analysis of an ORF 1a-encoding proteinase domain responsible for proteolytic processing of the infectious bronchitis virus 1a/1b polyprotein.
    Liu DX; Brown TD
    Virology; 1995 Jun; 209(2):420-7. PubMed ID: 7778277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterization of proteolytic processing of the Pol proteins of human foamy virus reveals novel features of the viral protease.
    Pfrepper KI; Rackwitz HR; Schnölzer M; Heid H; Löchelt M; Flügel RM
    J Virol; 1998 Sep; 72(9):7648-52. PubMed ID: 9696869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the avian retroviral protease in the activation of reverse transcriptase during virion assembly.
    Craven RC; Bennett RP; Wills JW
    J Virol; 1991 Nov; 65(11):6205-17. PubMed ID: 1717718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human T-cell leukemia virus type 1 protease protein expressed in Escherichia coli possesses aspartic proteinase activity.
    Saiga A; Tanaka T; Orita S; Sato A; Sato S; Hachisu T; Abe K; Kimura Y; Kondo Y; Fujiwara T
    Arch Virol; 1993; 128(3-4):195-210. PubMed ID: 8435041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of protein expression and virus-like particle formation in mammalian cell lines stably expressing HIV-1 gag and env gene products with or without active HIV proteinase.
    Kräusslich HG; Ochsenbauer C; Traenckner AM; Mergener K; Fäcke M; Gelderblom HR; Bosch V
    Virology; 1993 Feb; 192(2):605-17. PubMed ID: 8421902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the genome of feline foamy virus and its proteins shows distinct features different from those of primate spumaviruses.
    Winkler I; Bodem J; Haas L; Zemba M; Delius H; Flower R; Flügel RM; Löchelt M
    J Virol; 1997 Sep; 71(9):6727-41. PubMed ID: 9261397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloblastosis associated virus (MAV) proteinase site-mutated to be HIV-like has a higher activity and allows production of infectious but morphologically altered virus.
    Sedlacek J; Fabry M; Coward JE; Horejsi M; Strop P; Luftig RB
    Virology; 1993 Feb; 192(2):667-72. PubMed ID: 7678476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Point mutation in avian sarcoma leukaemia virus protease which increases its activity but impairs infectious virus production.
    Arad G; Chorev M; Shtorch A; Goldblum A; Kotler M
    J Gen Virol; 1995 Aug; 76 ( Pt 8)():1917-25. PubMed ID: 7543558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.